Jump to main content
Jump to site search

Issue 25, 2012
Previous Article Next Article

A novel C,D-spirolactone analogue of paclitaxel: autophagy instead of apoptosis as a previously unknown mechanism of cytotoxic action for taxoids

Author affiliations

Abstract

The design, synthesis and biological evaluation of a novel C,D-spirolactone analogue of paclitaxel is described. This is the first paclitaxel analogue without an oxetane D-ring that shows a significant cytotoxic effect (activity one order of magnitude lower than paclitaxel). More importantly, its cytotoxicity is a result of a different mechanism of action, involving mTOR inhibition-dependent autophagy instead of G2/M cell cycle arrest-dependent apoptosis.

Graphical abstract: A novel C,D-spirolactone analogue of paclitaxel: autophagy instead of apoptosis as a previously unknown mechanism of cytotoxic action for taxoids

Back to tab navigation

Supplementary files

Publication details

The article was received on 09 Mar 2012, accepted on 02 May 2012 and first published on 02 May 2012


Article type: Paper
DOI: 10.1039/C2OB25514F
Org. Biomol. Chem., 2012,10, 4933-4942

  •   Request permissions

    A novel C,D-spirolactone analogue of paclitaxel: autophagy instead of apoptosis as a previously unknown mechanism of cytotoxic action for taxoids

    M. V. Trmcic, R. V. Matovic, G. I. Tovilovic, B. Z. Ristic, V. S. Trajkovic, Z. B. Ferjancic and R. N. Saicic, Org. Biomol. Chem., 2012, 10, 4933
    DOI: 10.1039/C2OB25514F

Search articles by author

Spotlight

Advertisements